Avoro Capital Advisors LLC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:21 am Purchase | 2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 2,288,888 9.900% | 628,888 (+37.88%) | Filing |
| 2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,660,000 9.700% | 235,000 (+16.49%) | Filing |
| 2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,425,000 8.300% | 200,000 (+16.33%) | Filing |
| 2021-02-12 08:06 am Purchase | 2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,225,000 7.900% | 1,225,000 (New Position) | Filing |